Commercial drug | Product Name | Isotype |
8H9 | Anti-Human B7-H3 Monoclonal Antibody(Ombbio) | Human IgG1(K214R)-Kappa |
Abituzumab | Anti-Human CD51 Monoclonal Antibody(Abibio) | Human IgG1-Kappa |
Abrilumab | Anti-Human α4β7 Monoclonal Antibody(Abrbio) | Human IgG2-Kappa |
Aducanumab | Anti-Human Amyloid beta Monoclonal Antibody(Adubio) | Human IgG1(K214R)-Kappa |
Amatuximab | Anti-Human MSLN Monoclonal Antibody(Amabio) | Human IgG1(E356D/M358L)-Kappa |
Anifrolumab | Anti-Human IFNAR1 Monoclonal Antibody(Anibio) | Human IgG1(K214R/L351F/L352E/P331S)-Kappa |
Aprutumab | Anti-Human FGFR Monoclonal Antibody(Aprbio) | Human IgG1(E356D/M358L)-Lambda2 |
Atibuclimab | Anti-Human CD14 Monoclonal Antibody(Atibio) | Human IgG4-Kappa |
Bamlanivimab | Anti-Human SARS-CoV-2 Monoclonal Antibody(Bambio) | Human IgG1(K214R)-Kappa |
Bapineuzumab | Anti-Human APP Monoclonal Antibody(Bapbio) | Human IgG1-Kappa |
Batoclimab | Anti-Human FcRn Monoclonal Antibody(Batbio) | Human IgG1(K214R/L234A/L235A)-lambda2 |
Belantamab | Anti-Human BCMA Monoclonal Antibody(Belabio) | Human IgG1(E356D/M358L)-Kappa |
Belimumab | Anti-Human BAFF Monoclonal Antibody(Belbio) | Human IgG1(E356D/M358L)-Human lambda 2(K83R) |
Bemarituzumab | Anti-Human FGFR2 Monoclonal Antibody(Bembio) | Human IgG1(K214R)-Kappa |
Bexmarilimab | Anti-Human STAB1 Monoclonal Antibody(Bexbio) | Human IgG4(S228P/L235E)-Kappa |
Blosozumab | Anti-Human SOST Monoclonal Antibody(Blobio) | Human IgG4(S228P/KDel)-Kappa |
Bococizumab | Anti-Human PCSK9 Monoclonal Antibody(Bocbio) | Human IgG2(A330S/P331S)-Kappa |
Brentuximab | Anti-Human CD30 Monoclonal Antibody(Brebio) | Human IgG1(E356D/M358L)-Kappa |
Brodalumab | Anti-Human IL-17RA Monoclonal Antibody(Brobio) | Human IgG2-Kappa |
Burosumab | Anti-Human FGF23 Monoclonal Antibody(Burbio) | Human IgG1(E356D/M358L)-Kappa |
Camidanlumab | Anti-Human CD25 Monoclonal Antibody(Cambio) | Human IgG1(K214R/E356D/M358L)-Kappa |
Camrelizumab | Anti-Human PD1 Monoclonal Antibody(Camrbio) | Human IgG4 (S228P)-Kappa |
Canakinumab | Anti-Human IL-1B Monoclonal Antibody(Canbio) | Human IgG1 (K214R)-Kappa |
Carlumab | Anti-Human CCL2 Monoclonal Antibody(Carbio) | Human IgG1(E356D/M358L)-Kappa |
Cemiplimab | Anti-Human PD-1 Monoclonal Antibody(Cembio) | Human IgG4(S228P)-Kappa |
Cixutumumab | Anti-Human IGF1R Monoclonal Antibody(Cixbio) | Human IgG1-Kappa |
Clazakizumab | Anti-Human IL-6 Monoclonal Antibody(Clabio) | Human IgG1(K214R/N297A)-Kappa |
Codrituzumab | Anti-Human GPC3 Monoclonal Antibody(Codbio) | Human IgG1(E356D/M358L)-Kappa |
Cusatuzumab | Anti-Human CD70 Monoclonal Antibody(Cusbio) | Human IgG1(E356D/M358L)-Lambda2 |
Dacetuzumab | Anti-Human CD40 Monoclonal Antibody(Dacebio) | Human IgG1-Kappa |
Daclizumab | Anti-Human CD25 Monoclonal Antibody(Daclbio) | Human IgG1(E356D/M358L)-Kappa |
Daratumuab | Anti-Human CD38 Monoclonal Antibody(Darbio) | Human IgG1(K214R)-Kappa |
Daxdilimab | Anti-Human LILRA4 Monoclonal Antibody(Daxbio) | Human IgG1(K214R)-Lambda2(K83R) |
Denosumab | Anti-Human CD254 Monoclonal Antibody(Denbio) | Human IgG1(E356D/M358L)-Kappa |
Dupilumab | Anti-Human IL-4R Monoclonal Antibody(Dupbio) | Human IgG4(S228P/KDel)-Kappa |
Durvalumab | Anti-Human PD-L1 Monoclonal Antibody(Durbio) | Human IgG1(K214R/L234F/L235E/P331S)-Kappa |
Eculizumab | Anti-Human C5 Monoclonal Antibody(Ecubio) | Human IgG2CH1CH2(H264Q/F296Y/A326S/P327S/T335A)+IgG4CH3-Kappa |
Edrecolomab | Anti-Human CD326 Monoclonal Antibody(Edrbio) | Mouse IgG2A-kappa |
Efalizumab | Anti-Human CD11a Monoclonal Antibody(Efabio) | Human IgG1-Kappa |
Eldelumab | Anti-Human CXCL10 Monoclonal Antibody(Eldbio) | Human IgG1(K214R)-Kappa |
Elotuzumab | Anti-Human SLAMF7 Monoclonal Antibody(Elobio) | Human IgG1(E356D/M358L)-Kappa |
Emapalumab | Anti-Human IFN-gamma Monoclonal Antibody(Emabio) | Human IgG1(K214R)-Kappa |
Emibetuzumab | Anti-Human MET Monoclonal Antibody(Emibio) | Human IgG4(S228P/F234A/L235A/KDel)-Kappa |
Enfortumab | Anti-Human Nectin-4 Monoclonal Antibody(Enfbio) | Human IgG1(K214R)-Kappa |
Enibarcimab | Anti-Human ADM Monoclonal Antibody(Enibio) | Human IgG1(E356D/M358L)-Kappa |
Enoblituzumab | Anti-Human B7-H3 Monoclonal Antibody(Enobbio) | Human IgG1(K214R/L235V/ F243L/R292P/Y300L/P396L)-Kappa |
Enokizumab | Anti-Human IL-9 Monoclonal Antibody(Enobio) | Human IgG1(K214R)-Kappa |
Envafolimab | Anti-Human PD-L1 Monoclonal Antibody(Envbio) | VHH-hFC |
Eptinezumab | Anti-Human CGRP Monoclonal Antibody(Eptbio) | Human IgG1(K213A/K214R/F241T/N297A)-Kappa |
Erenumab | Anti-Human CGRP Monoclonal Antibody(Erebio) | Human IgG2-Lambda1 |
Etokimab | Anti-Human IL-33 Monoclonal Antibody(Etobio) | Human IgG1(E356D/M358L)-Kappa |
Etrolizumab | Anti-Human α4β7 Monoclonal Antibody(Etrbio) | Human IgG1(KDel)-Kappa |
Evinacumab | Anti-Human ANGPTL3 Monoclonal Antibody(Evibio) | Human IgG4(S228P)-Kappa |
Evolocumab | Anti-Human PCSK9 Monoclonal Antibody(Evobio) | Human IgG2-Kappa |
용량(Bulk가능) 및 자세한 문의는 바이오엑스셀코리아(주)로 연락 부탁 드립니다.
바이오엑스셀 코리아 (www.bioxcell.co.kr)